LEVONORGESTREL 1.5MG TABLET (BK000785)

Hazard statements (CLP)

H335, H351, H360

Code

Statements

H335

May cause respiratory irritation

SECTION 2: Hazards identification

Classification Carcinogenicity Category 2 Reproductive toxicity Category 1A Specific target organ toxicity (single exposure) Category 3 Appearance White Physical state Solid Odor Odorless

2.2 Label elements

Danger

Hazard statements

Suspected of causing cancer May damage fertility or the unborn child May cause respiratory irritation

Prevention

Obtain special instructions before use Do not handle until all safety precautions have been read and understood Wear protective gloves/protective clothing/eye protection/face protection Avoid breathing dust/fume/gas/mist/vapors/spray Use only outdoors or in a well-ventilated area

Response

IF exposed or concerned: Get medical advice/attention Inhalation IF INHALED: Remove person to fresh air and keep comfortable for breathing

Storage

Store locked up Store in a well-ventilated place. Keep container tightly closed

Precautionary statements

Disposal Dispose of contents/container to an approved waste disposal plant

Further information

Unknown acute toxicity 7.05 % of the mixture consists of ingredient(s) of unknown toxicity 7.05 % of the mixture consists of ingredient(s) of unknown acute oral toxicity 7.05 % of the mixture consists of ingredient(s) of unknown acute dermal toxicity 7.05 % of the mixture consists of ingredient(s) of unknown acute inhalation toxicity (gas) 7.05 % of the mixture consists of ingredient(s) of unknown acute inhalation toxicity (vapor) 7.05 % of the mixture consists of ingredient(s) of unknown acute inhalation toxicity (dust/mist)

2.1 Classification of the substance or mixture

Carcinogenicity Category 2 Reproductive toxicity Category 1A Specific target organ toxicity (single exposure) Category 3 Appearance White Physical state Solid Odor Odorless